Are Cutibacterium acnes present at the end of primary shoulder prosthetic surgeries responsible for infection? Prospective study.


Journal

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
ISSN: 1435-4373
Titre abrégé: Eur J Clin Microbiol Infect Dis
Pays: Germany
ID NLM: 8804297

Informations de publication

Date de publication:
Jan 2022
Historique:
received: 08 07 2021
accepted: 07 09 2021
pubmed: 19 9 2021
medline: 27 1 2022
entrez: 18 9 2021
Statut: ppublish

Résumé

The purpose of this study was to investigate if the C. acnes present at the end of a primary shoulder arthroplasty could be responsible for shoulder arthroplasty infection. Prospective study includes patients undergoing primary shoulder arthroplasty from January 2015 until December 2018. From all the patients included, 5 to 12 tissue samples were obtained and were specifically cultured to detect the presence of C. acnes. DNA was extracted from the C acnes isolated colonies and Whole Genome Sequencing (WGS) analysis was done. A cohort of 156 patients was finally included. In twenty-seven patients, the C. acnes was present at the end of the primary surgery. Two of these patients developed a C. acnes periprosthetic shoulder infection at 6 and 4 months after the primary surgery. WGS of C. acnes isolated colonies showed that all the revision-surgery isolates clustered near to the corresponding primary-surgery isolates compared to the other independent bacterial colonies. (99.89% of similarity). C. acnes present at the end of the primary surgery can be the cause of early or delayed periprosthetic joint infections in shoulder arthroplasty.

Identifiants

pubmed: 34535842
doi: 10.1007/s10096-021-04348-6
pii: 10.1007/s10096-021-04348-6
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

169-173

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Matsen FA III, Russ SM, Bertelsen A, Butler-Wu S, Pottinger PS (2015) Propionibacterium can be isolated from deep cultures obtained at primary arthroplasty despite intravenous antimicrobial prophylaxis. J Shoulder Elbow Surg 24:844–847. https://doi.org/10.1016/j.jse.2014.10.016
doi: 10.1016/j.jse.2014.10.016 pubmed: 25547858
El Sayed F, Roux AL, Sapriel G, Salomon E, Bauer T, Gailard JL et al (2019) Molecular typing of multiple isolates is essential to diagnose Cutibacterium acnes orthopedic device-related infection. Clin Infect Dis 68:1942–1945. https://doi.org/10.1093/cid/ciy952
doi: 10.1093/cid/ciy952 pubmed: 31098616
Torrens C, Marí R, Alier A, Puig LL, Santana F, Corvec S (2019) Cutibacterium acnes in primary reverse shoulder arthroplasty: from skin to deep layers. J Shoulder Elbow Surg 28:839–846. https://doi.org/10.1016/j.jse.2018.10.016
doi: 10.1016/j.jse.2018.10.016 pubmed: 30685278
Aubin GG, Lavigne JP, Foucher Y, Dellière S, Lepelletier D, Gouin F et al (2017) Tropism and virulence of Cutibacterium (formerly Propionibacterium) acnes involved in implant-associated infection. Anaerobe 47:73–78. https://doi.org/10.1016/j.anaerobe.2017.04.009
doi: 10.1016/j.anaerobe.2017.04.009 pubmed: 28454760
Rodriguez-R LM, Gunturu S, Harvey WT, Roselló-Mora R, Tiedje JM, Cole JR et al (2018) The Microbial Genomes Atlas (MiGA) webserver: taxonomic and gene diversity analysis of Archaea and Bacteria at the whole genome level. Nucleic Acids Res 46(W1):W282–W288. https://doi.org/10.1093/nar/gky467
doi: 10.1093/nar/gky467 pubmed: 29905870 pmcid: 6031002
Furustrand Tafin U, Corvec S, Betrisey B, Zimmerli W, Trampuz A (2012) Role of rifampicin against Propionibacterium acnes biofilm in vitro and in an experimental foreign-body infection model. Antimicrob Agents Chemother 56(4):1885–1891. https://doi.org/10.1128/AAC.05552-11
doi: 10.1128/AAC.05552-11 pubmed: 22252806 pmcid: 3318339
Corvec S (2018) Clinical and biological features of Cutibacterium (formerly Propionibacterium) avidum, an underrecognized microorganism. Clin Microbiol Rev 31(3):e00064-17. https://doi.org/10.1128/CMR.00064-17
doi: 10.1128/CMR.00064-17 pubmed: 29848774 pmcid: 6056840
Phadnis J, Gordon D, Krishnan J, Bain GI (2016) Frequent isolation of Propionibacterium acnes from the shoulder dermis despite skin preparation and prophylactic antibiotics. J Shoulder Elbow Surg 25:304–310. https://doi.org/10.1016/j.jse.2015.08.002
doi: 10.1016/j.jse.2015.08.002 pubmed: 26456428
Nakase K, Fukushima H, Yukawa T, Nakaminami H, Fujii T, Noguchi N (2018) Propionibacterium acnes has low susceptibility to chlorhexidine digluconate. Surg Infect (Larchmt) 19(3):298–302. https://doi.org/10.1089/sur.2017.220
doi: 10.1089/sur.2017.220
Kaveeshwar S, Duvall G, Jones DL, O’Hara NN, Klein A, Diedrich AM et al (2020) Risk factors for increased shoulder Cutibacterium acnes burden. JSES Int 4(3):454–469. https://doi.org/10.1016/j.jseint.2020.04.020
doi: 10.1016/j.jseint.2020.04.020
Bumgarner RE, Harrison D, Hsu JE (2020) Cutibacterium acnes isolates from deep tissue specimens retrieved during revision shoulder arthroplasty: similar colony morphology does not indicate clonality. J Clin Microbiol 58:e00121-19. https://doi.org/10.1128/JCM.00121-19
doi: 10.1128/JCM.00121-19 pubmed: 31645372 pmcid: 6989078
Bémer P, Plouzeau C, Tande D, Léger J, Giraudeau B, Valentin AS et al (2014) Evaluation of 16S rRNA gene PCR sensitivity and specificity for diagnosis of prosthetic joint infection: a prospective multicentric cross-sectional study. J Clin Microbiol 52(10):3583–3589. https://doi.org/10.1128/JCM.01459-14
doi: 10.1128/JCM.01459-14 pubmed: 25056331 pmcid: 4187742

Auteurs

Carlos Torrens (C)

Orthopaedic Department, Hospital del Mar, Passeig Marítim 25-29, 08003, Barcelona, Spain. 86925@parcdesalutmar.cat.

Beatriz Bellosillo (B)

Pathology Department, Hospital del Mar, Barcelona, Spain.
Cancer Research Program, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.

Joan Gibert (J)

Pathology Department, Hospital del Mar, Barcelona, Spain.
Cancer Research Program, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.

Albert Alier (A)

Orthopaedic Department, Hospital del Mar, Passeig Marítim 25-29, 08003, Barcelona, Spain.

Fernando Santana (F)

Orthopaedic Department, Hospital del Mar, Passeig Marítim 25-29, 08003, Barcelona, Spain.

Nuria Prim (N)

Microbiology Service, Laboratori de Referència de Catalunya, Hospital del Mar, Barcelona, Spain.

Stéphane Corvec (S)

Service de Bactériologie Et Des Contrôles Microbiologiques, Université de Nantes, CHU Nantes, CRCINA U1232, 44000, Nantes, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH